Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$64.58
0.190.3%
Last update: Oct 21, 4:07 PM
$64.51
0.120.19%
Exelixis Inc (EXEL) Stock Price, Quote, News & History
EXELNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Exelixis (NASDAQ:EXEL) through any online brokerage.
Other companies in Exelixis’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Exelixis has a consensus price target of $48.56.
The stock price for Exelixis (NASDAQ: EXEL) is $64.51 last updated October 21, 2026 at 4:07 PM EDT.
There are no upcoming dividends for Exelixis.
Exelixis does not have any upcoming earnings scheduled.
There is no upcoming split for Exelixis.
Exelixis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
